{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:20:58Z","timestamp":1794694858858,"version":"4.9.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS079618"],"award-info":[{"award-number":["NS079618"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1U54 HD083092"],"award-info":[{"award-number":["1U54 HD083092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U54 HD083092"],"award-info":[{"award-number":["U54 HD083092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"DOI":"10.13039\/100011516","name":"Beyond Batten Disease Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100011516","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Calpains are a class of non-lysosomal cysteine proteases that exert their regulatory functions via limited proteolysis of their substrates. Similar to the lysosomal and proteasomal systems, calpain dysregulation is implicated in the pathogenesis of neurodegenerative disease and cancer. Despite intensive efforts placed on the identification of mechanisms that regulate calpains, however, calpain protein modifications that regulate calpain activity are incompletely understood. Here we show that calpains are regulated by KCTD7, a cytosolic protein of previously uncharacterized function whose pathogenic mutations result in epilepsy, progressive ataxia, and severe neurocognitive deterioration. We show that KCTD7 works in complex with Cullin-3 and Rbx1 to execute atypical, non-degradative ubiquitination of calpains at specific sites (K398 of calpain 1, and K280 and K674 of calpain 2). Experiments based on single-lysine mutants of ubiquitin determined that KCTD7 mediates ubiquitination of calpain 1 via K6-, K27-, K29-, and K63-linked chains, whereas it uses K6-mediated ubiquitination to modify calpain 2. Loss of KCTD7-mediated ubiquitination of calpains led to calpain hyperactivation, aberrant cleavage of downstream targets, and caspase-3 activation. CRISPR\/Cas9-mediated knockout of\n                    <jats:italic>Kctd7<\/jats:italic>\n                    in mice phenotypically recapitulated human KCTD7 deficiency and resulted in calpain hyperactivation, behavioral impairments, and neurodegeneration. These phenotypes were largely prevented by pharmacological inhibition of calpains, thus demonstrating a major role of calpain dysregulation in KCTD7-associated disease. Finally, we determined that Cullin-3\u2013KCTD7 mediates ubiquitination of all ubiquitous calpains. These results unveil a novel mechanism and potential target to restrain calpain activity in human disease and shed light on the molecular pathogenesis of KCTD7-associated disease.\n                  <\/jats:p>","DOI":"10.1038\/s41421-023-00533-3","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T15:04:13Z","timestamp":1679670253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Calpain activity is negatively regulated by a KCTD7\u2013Cullin-3 complex via non-degradative ubiquitination"],"prefix":"10.1038","volume":"9","author":[{"given":"Jaiprakash","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalaka","family":"Mulherkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uan-I","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshya","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung-Kyu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ah","family":"Goo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon-Chiu Eastwood","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley F.","family":"Tolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"issue":"Pt 3","key":"533_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/bj3280721","volume":"328","author":"H Sorimachi","year":"1997","unstructured":"Sorimachi, H., Ishiura, S. & Suzuki, K. Structure and physiological function of calpains. Biochem. J. 328(Pt 3), 721\u2013732 (1997).","journal-title":"Biochem. J."},{"key":"533_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll, D. E., Thompson, V. F., Li, H., Wei, W. & Cong, J. The calpain system. Physiol. Rev. 83, 731\u2013801 (2003).","journal-title":"Physiol. Rev."},{"key":"533_CR3","doi-asserted-by":"publisher","first-page":"32719","DOI":"10.1074\/jbc.272.52.32719","volume":"272","author":"A Huttenlocher","year":"1997","unstructured":"Huttenlocher, A. et al. Regulation of cell migration by the calcium-dependent protease calpain. J. Biol. Chem. 272, 32719\u201332722 (1997).","journal-title":"J. Biol. Chem."},{"issue":"Pt 7","key":"533_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1242\/jcs.111.7.929","volume":"111","author":"SP Palecek","year":"1998","unstructured":"Palecek, S. P., Huttenlocher, A., Horwitz, A. F. & Lauffenburger, D. A. Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J. Cell Sci. 111(Pt 7), 929\u2013940 (1998).","journal-title":"J. Cell Sci."},{"key":"533_CR5","doi-asserted-by":"publisher","first-page":"36321","DOI":"10.1074\/jbc.274.51.36321","volume":"274","author":"K Croce","year":"1999","unstructured":"Croce, K. et al. Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J. Biol. Chem. 274, 36321\u201336327 (1999).","journal-title":"J. Biol. Chem."},{"key":"533_CR6","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1242\/jcs.02562","volume":"118","author":"SJ Franco","year":"2005","unstructured":"Franco, S. J. & Huttenlocher, A. Regulating cell migration: calpains make the cut. J. Cell Sci. 118, 3829\u20133838 (2005).","journal-title":"J. Cell Sci"},{"key":"533_CR7","first-page":"65","volume":"13","author":"HR Momeni","year":"2011","unstructured":"Momeni, H. R. Role of calpain in apoptosis. Cell J. 13, 65\u201372 (2011).","journal-title":"Cell J."},{"key":"533_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1527-3458.2006.00135.x","volume":"12","author":"A Camins","year":"2006","unstructured":"Camins, A., Verdaguer, E., Folch, J. & Pall\u00e0s, M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 12, 135\u2013148 (2006).","journal-title":"CNS Drug Rev."},{"key":"533_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","volume":"81","author":"I Richard","year":"1995","unstructured":"Richard, I. et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81, 27\u201340 (1995).","journal-title":"Cell"},{"key":"533_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.ajhg.2016.04.002","volume":"98","author":"Z Gan-Or","year":"2016","unstructured":"Gan-Or, Z. et al. Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia. Am. J. Hum. Genet. 98, 1038\u20131046 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"533_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.celrep.2016.05.044","volume":"16","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Defects in the CAPN1 gene result in alterations in cerebellar development and cerebellar ataxia in mice and humans. Cell Rep. 16, 79\u201391 (2016).","journal-title":"Cell Rep"},{"key":"533_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6593","volume":"5","author":"PMA Sleiman","year":"2014","unstructured":"Sleiman, P. M. A. et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat. Commun. 5, 5593 (2014).","journal-title":"Nat. Commun."},{"key":"533_CR13","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1093\/hmg\/ddaa198","volume":"29","author":"C Zha","year":"2020","unstructured":"Zha, C. et al. Biallelic variants in the small optic lobe calpain CAPN15 are associated with congenital eye anomalies, deafness and other neurodevelopmental deficits. Hum. Mol. Genet. 29, 3054\u20133063 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"533_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/79876","volume":"26","author":"Y Horikawa","year":"2000","unstructured":"Horikawa, Y. et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26, 163\u2013175 (2000).","journal-title":"Nat. Genet."},{"key":"533_CR15","doi-asserted-by":"publisher","first-page":"re1","DOI":"10.1126\/stke.114re1","volume":"1","author":"J Liu","year":"2008","unstructured":"Liu, J., Liu, M. C. & Wang, K. K. W. Calpain in the CNS: from synaptic function to neurotoxicity. Sci. Signal. 1, re1 (2008).","journal-title":"Sci. Signal."},{"key":"533_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1568-1637(03)00029-1","volume":"2","author":"RA Nixon","year":"2003","unstructured":"Nixon, R. A. The calpains in aging and aging-related diseases. Ageing Res. Rev. 2, 407\u2013418 (2003).","journal-title":"Ageing Res. Rev."},{"key":"533_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00401-002-0528-6","volume":"104","author":"E Adamec","year":"2002","unstructured":"Adamec, E., Mohan, P., Vonsattel, J. P. & Nixon, R. A. Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2. Acta Neuropathol. 104, 92\u2013104 (2002).","journal-title":"Acta Neuropathol."},{"key":"533_CR18","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1073\/pnas.90.7.2628","volume":"90","author":"K Saito","year":"1993","unstructured":"Saito, K., Elce, J. S., Hamos, J. E. & Nixon, R. A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA 90, 2628\u20132632 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"533_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/oxfordjournals.jbchem.a132111","volume":"84","author":"S Ishiura","year":"1978","unstructured":"Ishiura, S., Murofushi, H., Suzuki, K. & Imahori, K. Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization. J. Biochem. 84, 225\u2013230 (1978).","journal-title":"J. Biochem."},{"key":"533_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/312566a0","volume":"312","author":"S Ohno","year":"1984","unstructured":"Ohno, S. et al. Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein? Nature 312, 566\u2013570 (1984).","journal-title":"Nature"},{"key":"533_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jnr.10607","volume":"73","author":"JM Wingrave","year":"2003","unstructured":"Wingrave, J. M. et al. Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J. Neurosci. Res. 73, 95\u2013104 (2003).","journal-title":"J. Neurosci. Res."},{"key":"533_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbapap.2011.08.005","volume":"1824","author":"Y Ono","year":"2012","unstructured":"Ono, Y. & Sorimachi, H. Calpains: an elaborate proteolytic system. Biochim. Biophys. Acta 1824, 224\u2013236 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"533_CR23","doi-asserted-by":"publisher","first-page":"43126","DOI":"10.1074\/jbc.M408100200","volume":"279","author":"JL Hood","year":"2004","unstructured":"Hood, J. L., Brooks, W. H. & Roszman, T. L. Differential compartmentalization of the calpain\/calpastatin network with the endoplasmic reticulum and Golgi apparatus. J. Biol. Chem. 279, 43126\u201343135 (2004).","journal-title":"J. Biol. Chem."},{"key":"533_CR24","doi-asserted-by":"publisher","first-page":"33549","DOI":"10.1074\/jbc.M110.123604","volume":"285","author":"L Leloup","year":"2010","unstructured":"Leloup, L. et al. m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 285, 33549\u201333566 (2010).","journal-title":"J. Biol. Chem."},{"key":"533_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41422-020-0388-4","volume":"31","author":"E Metwally","year":"2021","unstructured":"Metwally, E., Zhao, G., Wang, Q. & Zhang, Y. Q. Ttm50 facilitates calpain activation by anchoring it to calcium stores and increasing its sensitivity to calcium. Cell Res. 31, 433\u2013449 (2021).","journal-title":"Cell Res."},{"key":"533_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/jmedgenet-2012-100859","volume":"49","author":"M Kousi","year":"2012","unstructured":"Kousi, M. et al. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene. J. Med. Genet. 49, 391\u2013399 (2012).","journal-title":"J. Med. Genet."},{"key":"533_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ajhg.2012.05.023","volume":"91","author":"JF Staropoli","year":"2012","unstructured":"Staropoli, J. F. et al. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system. Am. J. Hum. Genet. 91, 202\u2013208 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"533_CR28","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s00415-012-6545-z","volume":"259","author":"L Blumkin","year":"2012","unstructured":"Blumkin, L. et al. A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome. J. Neurol. 259, 2590\u20132598 (2012).","journal-title":"J. Neurol."},{"key":"533_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ana.21121","volume":"61","author":"P Van Bogaert","year":"2007","unstructured":"Van Bogaert, P. et al. Mutation of a potassium channel-related gene in progressive myoclonic epilepsy. Ann. Neurol. 61, 579\u2013586 (2007).","journal-title":"Ann. Neurol."},{"key":"533_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","volume":"18","author":"SE Mole","year":"2019","unstructured":"Mole, S. E. et al. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol. 18, 107\u2013116 (2019).","journal-title":"Lancet Neurol."},{"key":"533_CR31","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.bbadis.2015.04.001","volume":"1852","author":"SL Cotman","year":"2015","unstructured":"Cotman, S. L., Mole, S. E. & Kohan, R. Future perspectives: moving towards NCL treatments. Biochim. Biophys. Acta 1852, 2336\u20132338 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"533_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12035-011-8194-0","volume":"44","author":"R Azizieh","year":"2011","unstructured":"Azizieh, R. et al. Progressive myoclonic epilepsy-associated gene KCTD7 is a regulator of potassium conductance in neurons. Mol. Neurobiol. 44, 111\u2013121 (2011).","journal-title":"Mol. Neurobiol."},{"key":"533_CR33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ana.25351","volume":"84","author":"KA Metz","year":"2018","unstructured":"Metz, K. A. et al. KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect. Ann. Neurol. 84, 766\u2013780 (2018).","journal-title":"Ann. Neurol."},{"key":"533_CR34","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/sj.emboj.7600186","volume":"23","author":"L Pintard","year":"2004","unstructured":"Pintard, L., Willems, A. & Peter, M. Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. EMBO J. 23, 1681\u20131687 (2004).","journal-title":"EMBO J."},{"key":"533_CR35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ncb1103-950","volume":"5","author":"W Krek","year":"2003","unstructured":"Krek, W. BTB proteins as henchmen of Cul3-based ubiquitin ligases. Nat. Cell Biol. 5, 950\u2013951 (2003).","journal-title":"Nat. Cell Biol."},{"key":"533_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/bies.201300002","volume":"35","author":"M Skoblov","year":"2013","unstructured":"Skoblov, M. et al. Protein partners of KCTD proteins provide insights about their functional roles in cell differentiation and vertebrate development. Bioessays 35, 586\u2013596 (2013).","journal-title":"Bioessays"},{"key":"533_CR37","doi-asserted-by":"publisher","first-page":"e0126808","DOI":"10.1371\/journal.pone.0126808","volume":"10","author":"G Smaldone","year":"2015","unstructured":"Smaldone, G. et al. Cullin 3 recognition is not a universal property among KCTD proteins. PLoS ONE 10, e0126808 (2015).","journal-title":"PLoS ONE"},{"key":"533_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature08964","volume":"465","author":"J Schwenk","year":"2010","unstructured":"Schwenk, J. et al. Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 465, 231\u2013235 (2010).","journal-title":"Nature"},{"key":"533_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/2045-3701-3-45","volume":"3","author":"Z Liu","year":"2013","unstructured":"Liu, Z., Xiang, Y. & Sun, G. The KCTD family of proteins: structure, function, disease relevance. Cell Biosci. 3, 45 (2013).","journal-title":"Cell Biosci."},{"key":"533_CR40","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1073\/pnas.95.21.12123","volume":"95","author":"KF Ahmad","year":"1998","unstructured":"Ahmad, K. F., Engel, C. K. & Priv\u00e9, G. G. Crystal structure of the BTB domain from PLZF. Proc. Natl. Acad. Sci. USA 95, 12123\u201312128 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"533_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2005-6-10-r82","volume":"6","author":"PJ Stogios","year":"2005","unstructured":"Stogios, P. J., Downs, G. S., Jauhal, J. J. S., Nandra, S. K. & Priv\u00e9, G. G. Sequence and structural analysis of BTB domain proteins. Genome Biol. 6, R82 (2005).","journal-title":"Genome Biol."},{"key":"533_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S1097-2765(00)80481-5","volume":"3","author":"P Tan","year":"1999","unstructured":"Tan, P. et al. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol. Cell 3, 527\u2013533 (1999).","journal-title":"Mol. Cell"},{"key":"533_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1097-2765(00)80482-7","volume":"3","author":"T Ohta","year":"1999","unstructured":"Ohta, T., Michel, J. J., Schottelius, A. J. & Xiong, Y. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 3, 535\u2013541 (1999).","journal-title":"Mol. Cell"},{"key":"533_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1126\/science.284.5414.657","volume":"284","author":"T Kamura","year":"1999","unstructured":"Kamura, T. et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284, 657\u2013661 (1999).","journal-title":"Science"},{"key":"533_CR45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/416703a","volume":"416","author":"N Zheng","year":"2002","unstructured":"Zheng, N. et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416, 703\u2013709 (2002).","journal-title":"Nature"},{"key":"533_CR46","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1128\/MCB.20.12.4474-4481.2000","volume":"20","author":"JS Arthur","year":"2000","unstructured":"Arthur, J. S., Elce, J. S., Hegadorn, C., Williams, K. & Greer, P. A. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol. Cell. Biol. 20, 4474\u20134481 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"533_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/15216540050176610","volume":"50","author":"UJ Zimmerman","year":"2000","unstructured":"Zimmerman, U. J., Boring, L., Pak, J. H., Mukerjee, N. & Wang, K. K. The calpain small subunit gene is essential: its inactivation results in embryonic lethality. IUBMB Life 50, 63\u201368 (2000).","journal-title":"IUBMB Life"},{"key":"533_CR48","doi-asserted-by":"publisher","first-page":"baw054","DOI":"10.1093\/database\/baw054","volume":"2016","author":"V-N Nguyen","year":"2016","unstructured":"Nguyen, V.-N., Huang, K.-Y., Weng, J. T.-Y., Lai, K. R. & Lee, T.-Y. UbiNet: an online resource for exploring the functional associations and regulatory networks of protein ubiquitylation. Database (Oxford) 2016, baw054 (2016).","journal-title":"Database (Oxford)"},{"key":"533_CR49","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1097\/CCM.0b013e318246bb5d","volume":"40","author":"WB Nelson","year":"2012","unstructured":"Nelson, W. B., Smuder, A. J., Hudson, M. B., Talbert, E. E. & Powers, S. K. Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation. Crit. Care Med. 40, 1857\u20131863 (2012).","journal-title":"Crit. Care Med."},{"key":"533_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0006-8993(01)02874-8","volume":"916","author":"SK Ray","year":"2001","unstructured":"Ray, S. K., Matzelle, D. D., Wilford, G. G., Hogan, E. L. & Banik, N. L. Inhibition of calpain-mediated apoptosis by E-64 d-reduced immediate early gene (IEG) expression and reactive astrogliosis in the lesion and penumbra following spinal cord injury in rats. Brain Res. 916, 115\u2013126 (2001).","journal-title":"Brain Res."},{"key":"533_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-0173(03)00152-8","volume":"42","author":"SK Ray","year":"2003","unstructured":"Ray, S. K., Hogan, E. L. & Banik, N. L. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res. Brain Res. Rev. 42, 169\u2013185 (2003).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"533_CR52","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd.2016.212","volume":"15","author":"Y Ono","year":"2016","unstructured":"Ono, Y., Saido, T. C. & Sorimachi, H. Calpain research for drug discovery: challenges and potential. Nat. Rev. Drug Discov. 15, 854\u2013876 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"533_CR53","doi-asserted-by":"publisher","first-page":"e64627","DOI":"10.1371\/journal.pone.0064627","volume":"8","author":"OP Forman","year":"2013","unstructured":"Forman, O. P., De Risio, L. & Mellersh, C. S. Missense mutation in CAPN1 is associated with spinocerebellar ataxia in the Parson Russell Terrier dog breed. PLoS ONE 8, e64627 (2013).","journal-title":"PLoS ONE"},{"key":"533_CR54","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1083\/jcb.151.7.1583","volume":"151","author":"I Richard","year":"2000","unstructured":"Richard, I. et al. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha\/nuclear factor kappaB pathway perturbation in mice. J. Cell Biol. 151, 1583\u20131590 (2000).","journal-title":"J. Cell Biol."},{"key":"533_CR55","doi-asserted-by":"publisher","first-page":"e1003001","DOI":"10.1371\/journal.pgen.1003001","volume":"8","author":"VB Mahajan","year":"2012","unstructured":"Mahajan, V. B. et al. Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration. PLoS Genet. 8, e1003001 (2012).","journal-title":"PLoS Genet."},{"key":"533_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jid.2016.07.043","volume":"137","author":"R Bochner","year":"2017","unstructured":"Bochner, R. et al. Calpain 12 function revealed through the study of an atypical case of autosomal recessive congenital ichthyosis. J. Invest. Dermatol. 137, 385\u2013393 (2017).","journal-title":"J. Invest. Dermatol."},{"issue":"Pt 3","key":"533_CR57","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1042\/bj3180897","volume":"318","author":"A Baki","year":"1996","unstructured":"Baki, A., Tompa, P., Alexa, A., Moln\u00e1r, O. & Friedrich, P. Autolysis parallels activation of mu-calpain. Biochem. J. 318(Pt 3), 897\u2013901 (1996).","journal-title":"Biochem. J."},{"key":"533_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-5793(98)00856-4","volume":"433","author":"K Suzuki","year":"1998","unstructured":"Suzuki, K. & Sorimachi, H. A novel aspect of calpain activation. FEBS Lett 433, 1\u20134 (1998).","journal-title":"FEBS Lett"},{"key":"533_CR59","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0006-291X(86)80544-7","volume":"138","author":"M Inomata","year":"1986","unstructured":"Inomata, M., Imahori, K. & Kawashima, S. Autolytic activation of calcium-activated neutral protease. Biochem. Biophys. Res. Commun. 138, 638\u2013643 (1986).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"533_CR60","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/35012636","volume":"405","author":"MS Lee","year":"2000","unstructured":"Lee, M. S. et al. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360\u2013364 (2000).","journal-title":"Nature"},{"key":"533_CR61","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1093\/brain\/aww244","volume":"139","author":"MN Moen","year":"2016","unstructured":"Moen, M. N. et al. Pathogenic variants in KCTD7 perturb neuronal K+ fluxes and glutamine transport. Brain 139, 3109\u20133120 (2016).","journal-title":"Brain"},{"key":"533_CR62","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1172\/JCI34254","volume":"118","author":"F Trinchese","year":"2008","unstructured":"Trinchese, F. et al. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J. Clin. Invest. 118, 2796\u20132807 (2008).","journal-title":"J. Clin. Invest."},{"key":"533_CR63","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.apsb.2015.08.001","volume":"5","author":"M Siklos","year":"2015","unstructured":"Siklos, M., BenAissa, M. & Thatcher, G. R. J. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharm. Sin. B 5, 506\u2013519 (2015).","journal-title":"Acta Pharm. Sin. B"},{"key":"533_CR64","first-page":"134242","volume":"2015","author":"Z Zhang","year":"2015","unstructured":"Zhang, Z. et al. Therapeutic efficacy of E-64-d, a selective calpain inhibitor, in experimental acute spinal cord injury. Biomed. Res. Int. 2015, 134242 (2015).","journal-title":"Biomed. Res. Int."},{"key":"533_CR65","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/cns.13156","volume":"25","author":"X Teng","year":"2019","unstructured":"Teng, X. et al. KCTD: a new gene family involved in neurodevelopmental and neuropsychiatric disorders. CNS Neurosci. Ther. 25, 887\u2013902 (2019).","journal-title":"CNS Neurosci. Ther."},{"key":"533_CR66","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature11091","volume":"485","author":"C Golzio","year":"2012","unstructured":"Golzio, C. et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 485, 363\u2013367 (2012).","journal-title":"Nature"},{"key":"533_CR67","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ajhg.2015.04.008","volume":"96","author":"NE Mencacci","year":"2015","unstructured":"Mencacci, N. E. et al. A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. Am. J. Hum. Genet. 96, 938\u2013947 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"533_CR68","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","volume":"543","author":"Cancer Genome Atlas Research Network.","year":"2017","unstructured":"Cancer Genome Atlas Research Network. et al. Integrated genomic and molecular characterization of cervical cancer. Nature 543, 378\u2013384 (2017).","journal-title":"Nature"},{"key":"533_CR69","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/leu.2011.19","volume":"25","author":"PA Greif","year":"2011","unstructured":"Greif, P. A. et al. Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing. Leukemia 25, 821\u2013827 (2011).","journal-title":"Leukemia"},{"key":"533_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.8","volume":"5","author":"F Cathomas","year":"2015","unstructured":"Cathomas, F. et al. Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders. Transl. Psychiatry 5, e510 (2015).","journal-title":"Transl. Psychiatry"},{"key":"533_CR71","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1593\/neo.101630","volume":"13","author":"E De Smaele","year":"2011","unstructured":"De Smaele, E. et al. Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma. Neoplasia 13, 374\u2013385 (2011).","journal-title":"Neoplasia"},{"key":"533_CR72","doi-asserted-by":"publisher","first-page":"10833","DOI":"10.1073\/pnas.0400690101","volume":"101","author":"L Di Marcotullio","year":"2004","unstructured":"Di Marcotullio, L. et al. REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma. Proc. Natl. Acad. Sci. USA 101, 10833\u201310838 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"533_CR73","doi-asserted-by":"publisher","first-page":"104486","DOI":"10.1016\/j.neuint.2019.104486","volume":"129","author":"J Alevy","year":"2019","unstructured":"Alevy, J., Burger, C. A., Albrecht, N. E., Jiang, D. & Samuel, M. A. Progressive myoclonic epilepsy-associated gene Kctd7 regulates retinal neurovascular patterning and function. Neurochem. Int. 129, 104486 (2019).","journal-title":"Neurochem. Int."},{"key":"533_CR74","doi-asserted-by":"publisher","first-page":"20483","DOI":"10.1074\/jbc.M602180200","volume":"281","author":"Y Cao","year":"2006","unstructured":"Cao, Y. et al. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem. 281, 20483\u201320493 (2006).","journal-title":"J. Biol. Chem."},{"key":"533_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14338","volume":"8","author":"M Palmieri","year":"2017","unstructured":"Palmieri, M. et al. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat. Commun. 8, 14338 (2017).","journal-title":"Nat. Commun."},{"key":"533_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01716-1","volume":"7","author":"H Leinonen","year":"2017","unstructured":"Leinonen, H. et al. Retinal degeneration in A mouse model of CLN5 disease is associated with compromised autophagy. Sci. Rep. 7, 1597 (2017).","journal-title":"Sci. Rep."},{"key":"533_CR77","doi-asserted-by":"publisher","first-page":"e35493","DOI":"10.1371\/journal.pone.0035493","volume":"7","author":"M Thelen","year":"2012","unstructured":"Thelen, M. et al. Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS ONE 7, e35493 (2012).","journal-title":"PLoS ONE"},{"key":"533_CR78","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/hmg\/ddv615","volume":"25","author":"L Brandenstein","year":"2016","unstructured":"Brandenstein, L., Schweizer, M., Sedlacik, J., Fiehler, J. & Storch, S. Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7. Hum. Mol. Genet. 25, 777\u2013791 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"533_CR79","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrn1886","volume":"7","author":"MP Mattson","year":"2006","unstructured":"Mattson, M. P. & Magnus, T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7, 278\u2013294 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"533_CR80","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/02699052.2013.860479","volume":"28","author":"S Liu","year":"2014","unstructured":"Liu, S., Yin, F., Zhang, J. & Qian, Y. The role of calpains in traumatic brain injury. Brain Inj. 28, 133\u2013137 (2014).","journal-title":"Brain Inj."},{"key":"533_CR81","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.abb.2014.09.018","volume":"564","author":"D Moretti","year":"2014","unstructured":"Moretti, D., Del Bello, B., Allavena, G. & Maellaro, E. Calpains and cancer: friends or enemies? Arch. Biochem. Biophys. 564, 26\u201336 (2014).","journal-title":"Arch. Biochem. Biophys."},{"key":"533_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2303","volume":"3","author":"T Yamashita","year":"2012","unstructured":"Yamashita, T. et al. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 3, 1307 (2012).","journal-title":"Nat. Commun."},{"key":"533_CR83","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/hmg\/dds449","volume":"22","author":"J H\u00fcbener","year":"2013","unstructured":"H\u00fcbener, J. et al. Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3). Hum. Mol. Genet. 22, 508\u2013518 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"533_CR84","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni, J. & Ellerby, L. M. Calpain activation in Huntington\u2019s disease. J. Neurosci. 22, 4842\u20134849 (2002).","journal-title":"J. Neurosci."},{"key":"533_CR85","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","volume":"170","author":"BM Dufty","year":"2007","unstructured":"Dufty, B. M. et al. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am. J. Pathol. 170, 1725\u20131738 (2007).","journal-title":"Am. J. Pathol."},{"key":"533_CR86","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/cpdd.598","volume":"8","author":"H-K Lon","year":"2019","unstructured":"Lon, H.-K. et al. Pharmacokinetics, safety, tolerability, and pharmacodynamics of alicapistat, a selective inhibitor of human calpains 1 and 2 for the treatment of alzheimer disease: an overview of phase 1 studies. Clin. Pharmacol. Drug Dev. 8, 290\u2013303 (2019).","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"533_CR87","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1017\/S003118201600189X","volume":"144","author":"V Ennes-Vidal","year":"2017","unstructured":"Ennes-Vidal, V., Menna-Barreto, R. F. S., Branquinha, M. H., Dos Santos, A. L. S. & D\u2019Avila-Levy, C. M. Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis? Parasitology 144, 117\u2013123 (2017).","journal-title":"Parasitology"},{"key":"533_CR88","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1073\/pnas.97.2.588","volume":"97","author":"S Strobl","year":"2000","unstructured":"Strobl, S. et al. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc. Natl. Acad. Sci. USA 97, 588\u2013592 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"533_CR89","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0021-9258(18)51762-2","volume":"239","author":"G Guroff","year":"1964","unstructured":"Guroff, G. A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J. Biol. Chem. 239, 149\u2013155 (1964).","journal-title":"J. Biol. Chem."},{"key":"533_CR90","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.tins.2021.07.003","volume":"44","author":"E Metwally","year":"2021","unstructured":"Metwally, E., Zhao, G. & Zhang, Y. Q. The calcium-dependent protease calpain in neuronal remodeling and neurodegeneration. Trends Neurosci. 44, 741\u2013752 (2021).","journal-title":"Trends Neurosci."},{"key":"533_CR91","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399\u2013422 (2016).","journal-title":"Cell Res"},{"key":"533_CR92","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","volume":"18","author":"R Yau","year":"2016","unstructured":"Yau, R. & Rape, M. The increasing complexity of the ubiquitin code. Nat. Cell Biol. 18, 579\u2013586 (2016).","journal-title":"Nat. Cell Biol."},{"key":"533_CR93","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-051810-094654","volume":"81","author":"K Husnjak","year":"2012","unstructured":"Husnjak, K. & Dikic, I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 81, 291\u2013322 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"533_CR94","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203\u2013229 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"533_CR95","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrm3394","volume":"13","author":"Y Kulathu","year":"2012","unstructured":"Kulathu, Y. & Komander, D. Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat. Rev. Mol. Cell Biol. 13, 508\u2013523 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"533_CR96","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1073\/pnas.1404059112","volume":"112","author":"K Liu","year":"2015","unstructured":"Liu, K. et al. Altered ubiquitin causes perturbed calcium homeostasis, hyperactivation of calpain, dysregulated differentiation, and cataract. Proc. Natl. Acad. Sci. USA 112, 1071\u20131076 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-023-00533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-023-00533-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-023-00533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T15:05:26Z","timestamp":1679670326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-023-00533-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1038\/s41421-023-00533-3","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}